Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2872 | 2051 | 30.0 | 63% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
79 | 26608 | DIABETES CARE//DIABETES EDUCATOR//DIABETES TECHNOLOGY & THERAPEUTICS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CONTINUOUS SUBCUTANEOUS INSULIN INFUSION | Author keyword | 86 | 61% | 4% | 92 |
2 | CSII | Author keyword | 76 | 64% | 4% | 75 |
3 | INSULIN PUMP | Author keyword | 38 | 43% | 3% | 68 |
4 | INSULIN PUMP THERAPY | Author keyword | 35 | 62% | 2% | 37 |
5 | INSULIN ASPART | Author keyword | 30 | 46% | 2% | 49 |
6 | INSULIN LISPRO | Author keyword | 28 | 45% | 2% | 46 |
7 | MULTIPLE DAILY INJECTIONS | Author keyword | 25 | 75% | 1% | 18 |
8 | INSULIN GLULISINE | Author keyword | 17 | 62% | 1% | 18 |
9 | INSULIN PUMPS | Author keyword | 16 | 56% | 1% | 19 |
10 | LISPRO INSULIN | Author keyword | 15 | 82% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CONTINUOUS SUBCUTANEOUS INSULIN INFUSION | 86 | 61% | 4% | 92 | Search CONTINUOUS+SUBCUTANEOUS+INSULIN+INFUSION | Search CONTINUOUS+SUBCUTANEOUS+INSULIN+INFUSION |
2 | CSII | 76 | 64% | 4% | 75 | Search CSII | Search CSII |
3 | INSULIN PUMP | 38 | 43% | 3% | 68 | Search INSULIN+PUMP | Search INSULIN+PUMP |
4 | INSULIN PUMP THERAPY | 35 | 62% | 2% | 37 | Search INSULIN+PUMP+THERAPY | Search INSULIN+PUMP+THERAPY |
5 | INSULIN ASPART | 30 | 46% | 2% | 49 | Search INSULIN+ASPART | Search INSULIN+ASPART |
6 | INSULIN LISPRO | 28 | 45% | 2% | 46 | Search INSULIN+LISPRO | Search INSULIN+LISPRO |
7 | MULTIPLE DAILY INJECTIONS | 25 | 75% | 1% | 18 | Search MULTIPLE+DAILY+INJECTIONS | Search MULTIPLE+DAILY+INJECTIONS |
8 | INSULIN GLULISINE | 17 | 62% | 1% | 18 | Search INSULIN+GLULISINE | Search INSULIN+GLULISINE |
9 | INSULIN PUMPS | 16 | 56% | 1% | 19 | Search INSULIN+PUMPS | Search INSULIN+PUMPS |
10 | LISPRO INSULIN | 15 | 82% | 0% | 9 | Search LISPRO+INSULIN | Search LISPRO+INSULIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PUMP THERAPY | 113 | 50% | 8% | 164 |
2 | MULTIPLE DAILY INJECTIONS | 106 | 61% | 6% | 113 |
3 | PROB29 HUMAN INSULIN | 100 | 90% | 2% | 44 |
4 | INFUSION CSII | 75 | 91% | 2% | 31 |
5 | CSII | 72 | 79% | 2% | 46 |
6 | LISPRO | 71 | 40% | 7% | 140 |
7 | LYSB28 | 65 | 93% | 1% | 25 |
8 | SOLUBLE HUMAN INSULIN | 44 | 72% | 2% | 34 |
9 | LYSB28 PROB29 | 34 | 93% | 1% | 13 |
10 | ANALOG LYSB28 PROB29 | 30 | 100% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus | 2012 | 54 | 58 | 45% |
Hypoglycemia with Intensive Insulin Therapy: A Systematic Review and Meta-Analyses of Randomized Trials of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections | 2009 | 54 | 25 | 76% |
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion | 2008 | 149 | 42 | 55% |
Continuous subcutaneous insulin infusion at 25 years - Evidence base for the expanding use of insulin pump therapy in type 1 diabetes | 2002 | 180 | 47 | 89% |
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus | 2010 | 51 | 173 | 50% |
Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy | 2009 | 31 | 89 | 72% |
The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences | 2012 | 14 | 64 | 69% |
Management of diabetes mellitus: is the pump mightier than the pen? | 2012 | 11 | 65 | 75% |
Insulin analogues and their potential in the management of diabetes mellitus | 1999 | 195 | 115 | 62% |
Insulin treatment in children and adolescents with diabetes | 2009 | 33 | 121 | 52% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN METAB DIABET | 4 | 67% | 0.2% | 4 |
2 | DIABET PROD TEAM | 2 | 67% | 0.1% | 2 |
3 | INSULIN PHARMACOL HISTOL DELIVERY | 2 | 67% | 0.1% | 2 |
4 | DIABET ZENTRUM KINDER JUGENDLICHE | 2 | 22% | 0.3% | 6 |
5 | BD DIABET CHILDREN ADOLESCENTS | 1 | 50% | 0.1% | 2 |
6 | DIABET ZENTRUM KINDER JUDENDLICHE | 1 | 100% | 0.1% | 2 |
7 | HOP JEANNE ARCSERV DIABETOL MALAD METAB MALAD | 1 | 100% | 0.1% | 2 |
8 | MED DIABET PROGRAM | 1 | 100% | 0.1% | 2 |
9 | PEDIAT ENDOCRINOL DIABET CLIN | 1 | 50% | 0.1% | 2 |
10 | SERV MALAD ENDOCRINIENNES | 1 | 22% | 0.2% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000252600 | INSULIN PEN//FLEXPEN//VIAL AND SYRINGE |
2 | 0.0000202959 | ARTIFICIAL PANCREAS//DIABETES TECHNOLOGY & THERAPEUTICS//INSULIN DOSAGE ADJUSTMENT |
3 | 0.0000185576 | CARBOHYDRATE COUNTING//FLEXIBLE INTENSIVE INSULIN THERAPY//POPULATION BASED TRIAL |
4 | 0.0000174312 | INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30 |
5 | 0.0000161424 | INSULIN AUTOIMMUNE SYNDROME//INSULIN ALLERGY//INSULIN ANTIBODIES |
6 | 0.0000098623 | HYPOGLYCAEMIA UNAWARENESS//COUNTERREGULATION//HYPOGLYCAEMIA |
7 | 0.0000095217 | MONOMERIC INSULIN//INSULIN MUTANT//SINGLE CHAIN INSULIN |
8 | 0.0000089908 | ANTI RUST ACTIVITY//ANTI RUST ADDITIVES//CUTTING FLUID ADDITIVES |
9 | 0.0000089819 | PEDIATRIC DIABETES//METABOLIC CONTROL//INSULIN OMISSION |
10 | 0.0000070693 | INTERMITTENT GLUCOSE//POSTPRANDIAL HYPERGLYCEMIA//GLYCEMIC VARIABILITY |